Search research articles
Contact Us
Filters
Showing results (51-60 of 139) with videos related to
Page
of 14
Sort By:
The Journal of Molecular Diagnostics : JMD
|
December 26, 2021
Multiplex SuperSelective PCR Assays for the Detection and Quantitation of Rare Somatic Mutations in Liquid Biopsies
Diana Y Vargas, Sanjay Tyagi, Salvatore A E Marras, et al.
Cancer Discovery
|
March 28, 2020
Targeting HER2 with Trastuzumab Deruxtecan: A Dose-Expansion, Phase I Study in Multiple Advanced Solid Tumors
Junji Tsurutani, Hiroji Iwata, Ian Krop, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 27, 2018
Tumor Mutation Burden and Efficacy of EGFR-Tyrosine Kinase Inhibitors in Patients with <i>EGFR</i>-Mutant Lung Cancers
Michael Offin, Hira Rizvi, Megan Tenet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 14, 2018
Concurrent Alterations in EGFR-Mutant Lung Cancers Associated with Resistance to EGFR Kinase Inhibitors and Characterization of MTOR as a Mediator of Resistance
Helena A Yu, Ken Suzawa, Emmet Jordan, et al.
JTO Clinical and Research Reports
|
December 21, 2023
Intracranial Outcomes of De Novo Brain Metastases Treated With Osimertinib Alone in Patients With Newly Diagnosed EGFR-Mutant NSCLC
Brandon S Imber, Ryka Sehgal, Rachel Saganty, et al.
Cell Reports. Medicine
|
October 22, 2024
EGFR-directed antibodies promote HER2 ADC internalization and efficacy
Avantika Gupta, Flavia Michelini, Hong Shao, et al.
JCO Precision Oncology
|
September 14, 2020
CNS Metastases in Patients With <i>MET</i> Exon 14-Altered Lung Cancers and Outcomes With Crizotinib
Michael Offin, Jia Luo, Robin Guo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 14, 2019
Circulating Tumor DNA Profiling in Small-Cell Lung Cancer Identifies Potentially Targetable Alterations
Siddhartha Devarakonda, Sumithra Sankararaman, Brett H Herzog, et al.
Targeted Oncology
|
November 2, 2024
Adavosertib in Combination with Olaparib in Patients with Refractory Solid Tumors: An Open-Label, Dose-Finding, and Dose-Expansion Phase Ib Trial
Erika P Hamilton, Gerald S Falchook, Judy S Wang, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 10, 2025
Intracranial Disease Control and Survival among Patients with KRAS-mutant Lung Adenocarcinoma and Brain Metastases Treated with Stereotactic Radiosurgery
Benjamin Gaeta, Jordan E Eichholz, Henry Walch, et al.
Page
of 14
Search research articles
Search
Showing results (51-60 of 139) with videos related to
Sort By:
Page
of 14
The Journal of Molecular Diagnostics : JMD
|
December 26, 2021
Multiplex SuperSelective PCR Assays for the Detection and Quantitation of Rare Somatic Mutations in Liquid Biopsies
Diana Y Vargas, Sanjay Tyagi, Salvatore A E Marras, et al.
Cancer Discovery
|
March 28, 2020
Targeting HER2 with Trastuzumab Deruxtecan: A Dose-Expansion, Phase I Study in Multiple Advanced Solid Tumors
Junji Tsurutani, Hiroji Iwata, Ian Krop, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 27, 2018
Tumor Mutation Burden and Efficacy of EGFR-Tyrosine Kinase Inhibitors in Patients with <i>EGFR</i>-Mutant Lung Cancers
Michael Offin, Hira Rizvi, Megan Tenet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 14, 2018
Concurrent Alterations in EGFR-Mutant Lung Cancers Associated with Resistance to EGFR Kinase Inhibitors and Characterization of MTOR as a Mediator of Resistance
Helena A Yu, Ken Suzawa, Emmet Jordan, et al.
JTO Clinical and Research Reports
|
December 21, 2023
Intracranial Outcomes of De Novo Brain Metastases Treated With Osimertinib Alone in Patients With Newly Diagnosed EGFR-Mutant NSCLC
Brandon S Imber, Ryka Sehgal, Rachel Saganty, et al.
Cell Reports. Medicine
|
October 22, 2024
EGFR-directed antibodies promote HER2 ADC internalization and efficacy
Avantika Gupta, Flavia Michelini, Hong Shao, et al.
JCO Precision Oncology
|
September 14, 2020
CNS Metastases in Patients With <i>MET</i> Exon 14-Altered Lung Cancers and Outcomes With Crizotinib
Michael Offin, Jia Luo, Robin Guo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 14, 2019
Circulating Tumor DNA Profiling in Small-Cell Lung Cancer Identifies Potentially Targetable Alterations
Siddhartha Devarakonda, Sumithra Sankararaman, Brett H Herzog, et al.
Targeted Oncology
|
November 2, 2024
Adavosertib in Combination with Olaparib in Patients with Refractory Solid Tumors: An Open-Label, Dose-Finding, and Dose-Expansion Phase Ib Trial
Erika P Hamilton, Gerald S Falchook, Judy S Wang, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 10, 2025
Intracranial Disease Control and Survival among Patients with KRAS-mutant Lung Adenocarcinoma and Brain Metastases Treated with Stereotactic Radiosurgery
Benjamin Gaeta, Jordan E Eichholz, Henry Walch, et al.
Page
of 14